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Abstract Neuronal cell death can be determined by the
overall level of reactive oxygen species (ROS) resulting
from the combination of extrinsic sources and intrinsic
production as a byproduct of oxidative phosphorylation.
Key controllers of the intrinsic production of ROS are the
mitochondrial uncoupling proteins (UCPs). By allowing a
controlled leak of protons across the inner mitochondrial
membrane activation of these proteins can decrease ROS and
promote cell survival. In both primate models of Parkinson’s
disease and mouse models of seizures, increased activity of
UCP2 significantly increased neuronal cells survival. In the
retina UCP2 is expressed in many neurons and glial cells, but
was not detected in rod photoreceptors. Retinal ganglion cell
survival following excitotoxic damage was much greater in
animals overexpressing UCP2. Traditional Chinese medi-
cines, such as an extract of Cistanche tubulosa, may provide
benefit by altering mitochondrial metabolism.
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Introduction
Mitochondria
Mitochondria are essential organelles in all eukaryotic cells
and regulate a number of key processes including calcium
homeostasis, redox control, and several biosynthetic reac-
tions. Their most important role, however, is in energy
production where they serve as the major source of ATP
through oxidative phosphorylation. The inner mitochon-
drial membrane is highly impermeable and maintains a high
electrochemical gradient. Embedded in this membrane are
a series of transporters and enzymes that make up the
respiratory chain. This chain is made up of five separate
complexes and has over 80 protein constituents.
Oxidation of nutrient molecules gives rise to the reduced
forms of the hydrogen carriers FADH and NADH (reduced
cofactors). The reduced cofactors donate electrons to the three
of the five complexes of the electron transport chain. The large
drop in redox potential across these complexes provides the
driving force to pump protons out of the mitochondrial matrix
and create a large proton gradient across the membrane. The
energy in this gradient is coupled to ATP synthesis by the
complex five of the electron transport chain.
An obligatory consequence of these reactions is the
generation of reactive oxygen species (ROS) that have the
potential of damaging the cells. ROS exist in cells in
balance with a variety of antioxidants. Oxidative stress
occurs when the balance between ROS and antioxidants is
perturbed. The increase in ROS usually comes from
extrinsic mechanisms but it is the total ROS load that
determines whether a cell is damaged or not. Among the
mechanisms by which cells can reduce intrinsic ROS
production, and thus be more resistant to extrinsic ROS,
is the mild uncoupling that can be achieved through the
actions of uncoupling proteins.
Mitochondrial uncoupling proteins
Uncoupling proteins (UCPs) are members of the large gene
superfamily of mitochondrial anion carriers (reviewed in
C. J. Barnstable (*)
Department of Neural and Behavioral Sciences,
Penn State University College of Medicine,
Hershey, PA 17033, USA
e-mail: cbarnstable@psu.edu
j ocul biol dis inform (2009) 2:145–148
DOI 10.1007/s12177-009-9036-4
[1]). Based on sequence homologies uncoupling protein
genes have been identified in plants, protozoa, fungi, and
many vertebrates. Five uncoupling proteins have been
identified in mammals and all share certain common
structural elements (Fig. 1). All five are encoded by nuclear
genes and their protein products reside as integral proteins
of the inner mitochondrial membrane. The proteins have
three approximately 100 amino acid repeats, each with two
membrane spanning regions, and each of which has a
sequence defined as an energy transfer protein signature.
The canonical uncoupling protein in mammals is UCP1
which is found exclusively in brown fat, a tissue that uses
its energy stores to produce heat. UCP1 is the key molecule
in this process because it is able to allow a leak of protons
down their potential gradient from the intermembrane space
to the matrix of the mitochondria and the energy released
by this movement is dissipated as heat [2].
There is still debate about the full range of functions of
uncoupling proteins in other tissues. Each of the other UCPs
has a characteristic tissue distribution with UCP2 being one
of the most prevalent in the nervous system. UCP2 and some
of the other uncoupling proteins can, like UCP1, control the
leak of protons across the inner mitochondrial membrane [3].
One effect of this will be to reduce the endogenous
production of ROS and thus the overall ROS burden.
UCP2 may have a much more direct role in regulating ATP
production and the coupling of ATP levels to metabolic load
[4]. As regulators of energy metabolism in general, and
ROS production in particular, UCPs are ideal targets for
therapeutic agents. Because UCPs are distributed throughout
the body, they are also target for the holistic approaches that
characterize many forms of alternative medicine.
Uncoupling proteins and neuronal cell death
UCP2 can protect against oxidative stress
In our first experiments we asked whether overexpression
of UCP2 in neuronal cell lines could provide protection
against oxidative stress. Transfection of UCP2 plus GFP
into several different cell lines made the cells more resistant
Fig. 1 Alignment of mouse UCP protein sequences. The GenBank
Accession numbers used were AK002759 (UCP1), NM011671
(UCP2), NM009464 (UCP3), AK014394 (UCP4), and AF155812
(UCP5). The consensus sequence is shown below and identical
residues are shaded in gray. The three energy transfer protein
signatures are shown underneath in red
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to H2O2 than cells transfected with GFP alone [5]. Using a
low dose of H2O2 that killed about 30% of cells,
transfection of UCP2 completely abrogated the toxic effect
of the peroxide. Similarly, toxicity of NO was reduced from
40% cell death to less than 15%. We next studied several in
vivo models in different species and in different brain regions.
For example, activation of UCP2 by its cofactor coenzyme Q
protected neurons of the substantia nigra from damage
induced by the toxin MPTP [6]. In other experiments we
found that mice genetically engineered to overproduce
UCP2 were far more resistant to the effects of drug-
induced seizures [5]. Our conclusions from these studies
were that substances and metabolic conditions that favor
mitochondrial uncoupling can preserve neurons and poten-
tially slow the progression of neurodegenerative diseases.
UCP2 is expressed in the retina
Both PCR and immunocytochemical labeling indicated that
UCP2 is expressed in the retina [7]. Interestingly, we could
not find any evidence that rod photoreceptors express this
protein. Rods are one of the most metabolically active cells
in the body and it is possible that they cannot function
correctly if their mitochondria show any decrease in
coupling. Most, if not all, inner retinal cells express
UCP2. PCR analysis of cultured Müller cells detected the
presence of UCP2 RNA suggesting that both neurons and
glia can express this molecule.
To extend our studies in other parts of the CNS we asked
whether UCP2 could provide protection against excitotoxic
insults. We injected NMDA (160 nmol) or kainic acid
(20 nmol) into the eyes of wild-type, UCP2 overexpressing
transgenic mice or UCP2 knockout mice. After 24 h we
examined the retinas and counted the number of cells in the
ganglion cell layer (GCL). The NMDA-injected eyes of wild-
type mice and UCP2 knockout mice showed a 36% decrease
in cells in the GCL. The UCP2 transgenic mice, however,
had lost only 17% of cells. The results with kainate injection
were less dramatic but showed a similar trend. Wild-type and
UCP2 knockout animals lost 78% of cells in the GCL
whereas UCP2 transgenic animals lost 68% of cells.
UCP2 can regulate developmentally programmed cell death
During the first postnatal week mouse retinal ganglion cells
(RGC) undergo maturation such that the number of RGCs
in various strains of mice decrease from numbers of
131,000 to 224,000 at birth to 45,000 to 76,000 in the
adult [8, 9]. The regulation of developmental RGC death is
not fully understood but is linked, in part, to appropriate
functional connections to target cells. Neurotrophic factors
can delay or reduce RGC death and factors derived from
postsynaptic cells may play a regulatory role in the process
[10–12]. Although the signals responsible for controlling cell
survival or cell death at this time are not fully understood, it is
well established that the cells die through an apoptotic
mechanism. We examined the numbers of apoptotic cells in
the C57Bl/6 mouse GCL through the first postnatal week.
Wild-type animals showed an increasing number of degen-
erating cells during the first postnatal days with the peak
number at PN4, and this was followed by rapid decline over
the next 2 days. UCP2 overexpressing mice on the other hand
showed approximately 60% fewer degenerating cells at each
time point. As might be expected, the end result of this
decrease in cell death were retinas that had a thicker ganglion
cell layer in patches across the tissue even in to the adult.
Herbal treatments may act at the level of the mitochondria
Herba Cistanches, the stems of Cistanche species, is a
common traditional Chinese medicine and has been named
the “Ginseng of the Desert”. Its use was first recorded in
about 100 BC in Shen Nong Bencao Jing and is still used to
treat a wide variety of ailments. Four major Cistanche
species belong to the same genus but the molecular
fingerprints of the four are very different [13]. Cistanche
tubulosa was first described in an ophthalmology text in
1644 AD. An extract of this plant is produced commercially
and has been approved for use as a treatment for dementia
by the Chinese FDA. A wide variety of phenylethanoid
glycosides have been isolated from Cistanche species and
some of these are pharmacologically active [14].
Treatment of mammalian cells with an extract of
C. tubulosa led to an increase in mitochondrial membrane
potential and to changes in expression of genes related to
mitochondria including subunits of ATP synthase, enzymes
involved in Krebs cycle and heat shock proteins related to
mitochondria (Zhang et al. unpublished results). Further
work is needed to dissect this effect and determine how
much of the mitochondrial effect is directly on components
of the electron transport chain and how much on regulatory
proteins such as the uncoupling proteins.
The complexity of the extract used in these experiments
makes it difficult to determine whether a single ingredient is
responsible for all the effects or multiple ingredients act on
different pathways. Nevertheless, these preliminary experi-
ments give support to the idea that traditional Chinese
medicine approaches are effective because they target the
same pathways as Western medicine.
Discussion
From the above review it is clear that activation of UCP2
can provide protection from a wide variety of insults that
can lead to neural cell death. Though we have yet to test the
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role of UCP2 in any model of retinal degenerative disease,
we predict that activation of UCP2 will slow the progres-
sion of any disease that involves apoptosis or mitochondrial
dysfunction. Another conclusion from these and many
other studies is that mitochondria are key determinants of
cell death or survival. They act to integrate a wide variety
of signals and can precipitate cell death directly through
opening of the transition pore and release of cytochrome C,
or indirectly through alteration of redox state and cytoplas-
mic calcium levels.
We currently have only a few compounds that can alter
UCP2 activity. These include nucleotides, some fatty acids,
and coenzyme Q. As more becomes known about the ways in
which these molecules activate UCP2 there will undoubtedly
be a search for chemicals that mimic these actions. Given the
length of time that traditional Chinese medicine has had to
experiment and refine treatments, it should not be surprising
that there are medicines that act at key metabolic sites within
cells such as the mitochondria. Traditional medicines also
represent a more holistic approach and again, we should not
be surprised that effective medicines target multiple aspects
of cells or organelles that are shared among various tissues.
The challenge now is to decide whether to promote the
use of traditional medicines in their present form or to try
and dissect their active ingredients and try to formulate
mixtures of these that have the same effect.
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